Main Article Content
This retrospective study was conducted to analyze clinical and laboratoristic parameters to individuate specific differences and facilitate differential diagnosis between Measles and Kawasaki Disease (KD) at first evaluation in a emergency room. We found similar clinical features as duration of fever and number of KD criteria (p >0.5) but significant differences in white blood cell count, neutrophils, CRP and LDH levels (p < 0.001). LDH value ≥ 800 mg/dl had sensibility of 89% and specificity of 90% for Measles while CRP ≥ 3 mg/dl had sensibility 89% and specificity of 85% for KD. The combined use of CRP, LDH and AST showed accuracy of 86.67%.
Downloads month by month
3- WHO, United Nations Children’s Fund. Global immunization vision and strategy 2006–2015. 2005. Geneva, Switzerland: World Health Organization.
4- Centers for Disease Control and Prevention. Progress toward measles control—African region, 2001–2008. MMWR Morb Mortal Wkly Rep. 2009; 58: 1036–41.
5- World Health Organization Regional Committee for Africa. Towards the elimination of measles in the African region by 2020. Report of the Regional Director. 2009.
6- Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153-164.
7- McCrindle BW, Rowley AH, Newburger JW et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-e999.
9- Yanase Y, Tango T, Okumura Ko et al. A Comparative Study of Alteration in Lymphocyte Subsets among Varicella, Hand-Foot-and-Mouth Disease, Scarlet Fever, Measles, and Kawasaki Disease. Microbiology and Immunology. July 1987; Volume 31(7): 701–710.
10- Kim HS, Kim WD, Lee YH. Production and expression of Gro-alpha and RANTES by peripheral blood mononuclear cells isolated from patients with Kawasaki disease and measles. J Korean Med Sci. 2003;18(3):381–386.
11- Furukawa S, Matsubara T, Yone K et al. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum. European Journal of Pediatrics. January 1992; Volume 151(1): 44–47